Abstract
Background
We assessed the effect of T stage, Fuhrman’s grade, multifocality, bilaterality, positive surgical margins, and synchronism of bilateral tumors on cancer-specific survival of patients with nonmetastatic renal-cell carcinoma (RCC) undergoing nephron-sparing surgery for imperative indications.
Methods
We retrospectively analyzed 168 patients who underwent nephron-sparing surgery for imperative RCC indications between 1974 and 2002. A total of 85 patients had bilateral RCCs; in 27 patients, the tumors were multifocal. Multivariate Cox proportional hazards models were fitted to assess the features associated with cancer-specific survival.
Results
The median follow-up was 99 months (range, 2–326 months). Patients were followed until January 2008. A total of 52 patients died of their cancer during follow-up. Multivariate analyses of the total group only revealed Fuhrman’s grade 3 (hazard ratio [HR] 2.94) and bilateral occurrence of RCC (HR 1.82) as independent prognostic factors. In a subgroup analysis of patients with bilateral occurrence of RCC, we observed a tendency toward positive surgical margins (HR 2.89, P = 0.08) being another negative prognostic factor. There was no difference in cancer-specific survival between patients with synchronous and metachronous bilateral RCC presence (HR 1.08).
Conclusions
Fuhrman’s grade 3 and bilateral occurrence of RCC were the only statistically significant prognostic factors for cancer-specific survival in patients undergoing nephron-sparing surgery for imperative indications for nonmetastatic RCC. The presence of sporadic multifocal tumors and the synchronous occurrence of bilateral tumors have no influence on cancer-specific survival, while positive surgical margins may have an impact in the subset of patients with bilateral RCC.
Similar content being viewed by others
References
Pahernik S, Roos F, Wiesner C, Thuroff JW. Nephron sparing surgery for renal cell carcinoma in a solitary kidney. World J Urol. 2007;25:513–7.
Patard JJ, Pantuck AJ, Crepel M, et al. Morbidity and clinical outcome of nephron-sparing surgery in relation to tumour size and indication. Eur Urol. 2007;52:148–54.
Licht MR, Novick AC. Nephron sparing surgery for renal cell carcinoma. J Urol. 1993;149:1–7.
Morgan WR, Zincke H. Progression and survival after renal-conserving surgery for renal cell carcinoma: experience in 104 patients and extended followup. J Urol. 1990;144:852–7.
Butler BP, Novick AC, Miller DP, Campbell SA, Licht MR. Management of small unilateral renal cell carcinomas: radical versus nephron-sparing surgery. Urology. 1995;45:34–40.
Lerner SE, Hawkins CA, Blute ML, et al. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery. J Urol. 1996;155:1868–73.
Denzinger S, Ganzer R, Fink A, Wieland WF, Blana A. Open partial nephrectomy for imperative and elective indications: comparison of peri-operative data and long-term follow-up. Scand J Urol Nephrol. 2007;41:496–500.
Pahernik S, Roos F, Hampel C, et al. Nephron sparing surgery for renal cell carcinoma with normal contralateral kidney: 25 years of experience. J Urol. 2006;175:2027–31.
Krejci KG, Blute ML, Cheville JC, et al. Nephron-sparing surgery for renal cell carcinoma: clinicopathologic features predictive of patient outcome. Urology. 2003;62:641–6.
Gacci M, Rizzo M, Lapini A, et al. Imperative indications for conservative surgery for renal cell carcinoma: 20 years’ experience. Urol Int. 2001;67:203–8.
Pahernik S, Cudovic D, Roos F, Melchior SW, Thuroff JW. Bilateral synchronous sporadic renal cell carcinoma: surgical management, oncological and functional outcomes. BJU Int. 2007;100:26–9.
Hafez KS, Fergany AF, Novick AC. Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging. J Urol. 1999;162:1930–3.
Roos FC, Pahernik S, Elsasser A, et al. [Imperative nephron-sparing surgery for cases of solitary kidney/bilateral tumors: long-term results]. Der Urologe Ausg. 2008;47:818–23.
Margulis V, Tamboli P, Jacobsohn KM, Swanson DA, Wood CG. Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma. BJU Int. 2007;100:1235–9.
Zigeuner R, Quehenberger F, Pummer K, Petritsch P, Hubmer G. Long-term results of nephron-sparing surgery for renal cell carcinoma in 114 patients: risk factors for progressive disease. BJU Int. 2003;92:567–71.
Fergany AF, Hafez KS, Novick AC. Long-term results of nephron sparing surgery for localized renal cell carcinoma: 10-year followup. J Urol. 2000;163:442–5.
Ghavamian R, Cheville JC, Lohse CM, et al. Renal cell carcinoma in the solitary kidney: an analysis of complications and outcome after nephron sparing surgery. J Urol. 2002;168:454–9.
Belldegrun A, Tsui KH, deKernion JB, Smith RB. Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system. J Clin Oncol. 1999;17:2868–75.
Antonelli A, Cozzoli A, Nicolai M, et al. Nephron-sparing surgery versus radical nephrectomy in the treatment of intracapsular renal cell carcinoma up to 7 cm. Eur Urol. 2008;53:803–9.
Black P, Filipas D, Fichtner J, Hohenfellner R, Thuroff JW. Nephron sparing surgery for central renal tumors: experience with 33 cases. J Urol. 2000;163:737–43.
Duvdevani M, Laufer M, Kastin A, et al. Is frozen section analysis in nephron sparing surgery necessary? A clinicopathological study of 301 cases. J Urol. 2005;173:385–7.
Timsit MO, Bazin JP, Thiounn N, et al. Prospective study of safety margins in partial nephrectomy: intraoperative assessment and contribution of frozen section analysis. Urology. 2006;67:923–6.
Zucchi A, Mearini L, Mearini E, et al. Renal cell carcinoma: histological findings on surgical margins after nephron sparing surgery. J Urol. 2003;169:905–8.
Sutherland SE, Resnick MI, Maclennan GT, Goldman HB. Does the size of the surgical margin in partial nephrectomy for renal cell cancer really matter? J Urol. 2002;167:61–4.
Bensalah K, Pantuck AJ, Rioux-Leclercq N, et al. Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery. Eur Urol. 2009.
Thrasher JB, Robertson JE, Paulson DF. Expanding indications for conservative renal surgery in renal cell carcinoma. Urology. 1994;43:160–8.
Patard JJ, Leray E, Rioux-Leclercq N, et al. Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol. 2005;23:2763–71.
Becker F, Siemer S, Tzavaras A, Suttmann H, Stoeckle M. Long-term survival in bilateral renal cell carcinoma: a retrospective single-institutional analysis of 101 patients after surgical treatment. Urology. 2008;72:349–53.
Klatte T, Patard JJ, Wunderlich H, et al. Metachronous bilateral renal cell carcinoma: risk assessment, prognosis and relevance of the primary-free interval. J Urol. 2007;177:2081–6.
Bani-Hani AH, Leibovich BC, Lohse CM, et al. Associations with contralateral recurrence following nephrectomy for renal cell carcinoma using a cohort of 2,352 patients. J Urol. 2005;173:391–4.
Klatte T, Wunderlich H, Patard JJ, et al. Clinicopathological features and prognosis of synchronous bilateral renal cell carcinoma: an international multicentre experience. BJU Int. 2007;100:21–5.
Junker K, Thrum K, Schlichter A, et al. Clonal origin of multifocal renal cell carcinoma as determined by microsatellite analysis. J Urol. 2002;168:2632–6.
Miyake H, Nakamura H, Hara I, et al. Multifocal renal cell carcinoma: evidence for a common clonal origin. Clin Cancer Res. 1998;4:2491–4.
Raz O, Mendlovic S, Leibovici D, et al. The prevalence of malignancy in satellite renal lesions and its surgical implication during nephron sparing surgery. J Urol. 2007;178:1892–5.
Whang M, O’Toole K, Bixon R, et al. The incidence of multifocal renal cell carcinoma in patients who are candidates for partial nephrectomy. J Urol. 1995;154:968–70.
Lang H, Lindner V, Martin M, et al. Prognostic value of multifocality on progression and survival in localized renal cell carcinoma. Eur Urol. 2004;45:749–53.
Baltaci S, Orhan D, Soyupek S, et al. Influence of tumor stage, size, grade, vascular involvement, histological cell type and histological pattern on multifocality of renal cell carcinoma. J Urol. 2000;164:36–9.
Krambeck A, Iwaszko M, Leibovich B, et al. Long-term outcome of multiple ipsilateral renal tumours found at the time of planned nephron-sparing surgery. BJU Int. 2008;101:1375–9.
Blute ML, Thibault GP, Leibovich BC, et al. Multiple ipsilateral renal tumors discovered at planned nephron sparing surgery: importance of tumor histology and risk of metachronous recurrence. J Urol. 2003;170:760–3.
Author information
Authors and Affiliations
Corresponding author
Additional information
A. Haferkamp and M. Kurosch—contributed equally to this article.
Rights and permissions
About this article
Cite this article
Haferkamp, A., Kurosch, M., Pritsch, M. et al. Prognostic Factors Influencing Long-Term Survival of Patients Undergoing Nephron-Sparing Surgery for Nonmetastatic Renal-Cell Carcinoma (RCC) with Imperative Indications. Ann Surg Oncol 17, 544–551 (2010). https://doi.org/10.1245/s10434-009-0812-y
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-009-0812-y